Skip to main content

Table 6 Multivariate analysis of prognostic factors for overall survival

From: Clinical implications of the quantitative detection of ID4 gene methylation in myelodysplastic syndrome

  P value HR (95% CI)
Age (years) 0.007 6.277 (2.417 to 16.300)
Sex (male/female) <0.001 4.119 (1.466 to 11.578)
Hemoglobin (g/L) 0.731 0.997 (0.983 to 1.012)
WBC (×109/L) 0.738 1.014 (0.935 to 1.100)
Platelet (×109/L) 0.823 1.000 (0.995 to 1.004)
BM blast (%) 0.245 1.041 (0.973 to 1.114)
IPSS risk group <0.001 7.374 (3.746 to 14.518)
ID4 methylation level 0.011 2.371 (1.221 to 4.602)
  1. BM, bone marrow; WBC, blood cell counts; IPSS, International Prognostic Scoring System; ID4, inhibitor of DNA binding 4, 95% CI, 95% confidence interval.